The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation

Cited by (726)

Items 301–400 of 726

1. Mathematically Modeling Anhedonia in Schizophrenia: A Stochastic Dynamical Systems Approach
   Gregory P. Strauss, Farnaz Zamani Esfahlani, Eric L. Granholm, Jason L. Holden, Katherine Frost Visser, Lisa A. Bartolomeo, Hiroki Sayama · 2020 · Schizophrenia Bulletin
2. Focusing on recovery goals improves motivation in first-episode psychosis
   Daniel Fulford, Piper Meyer-Kalos, Kim T. Mueser · 2020 · Social Psychiatry and Psychiatric Epidemiology
3. Both unmedicated and medicated individuals with schizophrenia show impairments across a wide array of cognitive and reinforcement learning tasks
   Erin K. Moran, James M. Gold, Cameron S. Carter, Angus W. MacDonald, John Daniel Ragland, Steven M. Silverstein, Steven J. Luck, Deanna M. Barch · 2020 · Psychological Medicine
4. Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls
   Maike Engel, Tania M. Lincoln · 2016 · Psychiatry Research
5. Brain Age Gap in Early Illness Schizophrenia and the Clinical High-Risk Syndrome: Associations With Experiential Negative Symptoms and Conversion to Psychosis
   Jessica P.Y. Hua, Samantha V. Abram, Rachel L. Loewy, Barbara K. Stuart, Susanna L. Fryer, Sophia Vinogradov, Daniel H. Mathalon · 2024 · Schizophrenia Bulletin
6. COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS)
   Simon Geck, Maximilian Roithmeier, Markus Bühner, Sophia Wehr, Lucia Weigel, Josef Priller, John M. Davis, Stefan Leucht · 2025 · EClinicalMedicine
7. Ante el nuevo reto de identificar el síndrome negativo de la esquizofrenia
   María Paz García‐Portilla, Julio Bobes · 2013 · Revista de Psiquiatría y Salud Mental
8. Reward processing electrophysiology in schizophrenia: Effects of age and illness phase
   Samantha V. Abram, Brian J. Roach, Clay B. Holroyd, Martin P. Paulus, Judith M. Ford, Daniel H. Mathalon, Susanna L. Fryer · 2020 · NeuroImage Clinical
9. Negative schizophrenic symptoms as prefrontal cortex dysfunction: Examination using a task measuring goal neglect
   Paola Fuentes‐Claramonte, Núria Ramiro, Llanos Torres, Isabel Argila‐Plaza, Pilar Salgado‐Pineda, Joan Soler‐Vidal, María Ángeles García‐León, Àuria Albacete, Clara Bosque, Francesco Panicali et al. · 2022 · NeuroImage Clinical
10. Isolation of Distinct Networks Driving Action and Cognition in Psychomotor Processes
    Alexandra B. Moussa‐Tooks, Adam Beermann, Karlos Manzanarez Felix, Michael Coleman, Sylvain Bouix A, Daphne J. Holt, Kathryn E. Lewandowski, Döst Öngür, Alan F. Breier, Martha Elizabeth Shenton et al. · 2024 · Biological Psychiatry
11. The negative syndrome of schizophrenia: Three -underlying components are better than two
    María Paz García‐Portilla, Leticia García-Álvarez, Anna Mané, Clemente García‐Rizo, Gisela Sugranyes, Daniel Bergé, Miquel Bernardo, Emilio Fernández-Egea, Julio Bobes · 2015 · Schizophrenia Research
12. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders
    Gisela Mezquida, Rafael Penadés, Bibiana Cabrera, George Savulich, António Lobo, Ana María González-Pinto, María José Penzol, Iluminada Corripio, Emilio Fernández-Egea, Patricia Gassó et al. · 2016 · European Psychiatry
13. Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms – Results from an exploratory re-analysis
    Maximilian Hansbauer, Thomas Wobrock, Birgit Kunze, Berthold Langguth, Michael Landgrebe, Peter Eichhammer, Elmar Frank, Joachim Cordes, Wolfgang Wölwer, Georg Winterer et al. · 2018 · Psychiatry Research
14. Evaluating visual neuroplasticity with EEG in schizophrenia outpatients
    Jonathan K. Wynn, Brian J. Roach, Amanda McCleery, Stephen R. Marder, Daniel H. Mathalon, Michael Foster Green · 2019 · Schizophrenia Research
15. Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats
    Jana Lotter, Marisa Möller, Olivia May Dean, Michael Berk, Brian Herbert Harvey · 2020 · Frontiers in Psychiatry
16. Effects of aerobic exercise on cardiorespiratory fitness and social functioning in veterans 40 to 65 years old with schizophrenia
    Kern, Robert S., Reddy, L. Felice, Cohen, Amy N., Young, Alexander S., Green, Michael F. · 2020 · Psychiatry Research
17. How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domain
    Mariia Kaliuzhna, Matthias Kirschner, Fabien Carruzzo, Matthias N. Hartmann-Riemer, Martin Bischof, Erich Seifritz, Philippe N. Tobler, Stefan Kaiser · 2021 · Schizophrenia Research
18. Smartphone-based mobility metrics capture daily social motivation and behavior in schizophrenia
    Jessica L. Mow, David E. Gard, Kim T. Mueser, Jasmine Mote, Kathryn Gill, Lawrence Leung, Tairmae Kangarloo, Daniel Fulford · 2022 · Schizophrenia Research
19. Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex
    Lejia Fan, Liangbing Liang, Yujue Wang, Xiaoqian Ma, Yuan Liu, Lijun Ouyang, Ying Hé, Zongchang Li, Chunwang Li, Xiaogang Chen et al. · 2023 · Neuropsychopharmacology
20. Clinical Assessment Interview for Negative Symptoms (CAINS): A Systematic Review of Measurement Properties
    Sophia Wehr, Lucia Weigel, John M. Davis, Silvana Galderisi, Armida Mucci, Stefan Leucht · 2023 · Schizophrenia Bulletin
21. Profiling of experiential pleasure, emotional regulation and emotion expression in patients with schizophrenia
    Ying-min Zou, Ke Ni, Zhuo‐ya Yang, Ying Li, Xin‐lu Cai, Dongjie Xie, Ruiting Zhang, Fuchun Zhou, Wenxiu Li, Simon S. Y. Lui et al. · 2017 · Schizophrenia Research
22. Polish version of the Brief Negative Symptom Scale (BNSS)
    Paweł Wójciak, Krystyna Górna, Klaudia Domowicz, Krystyna Jaracz, Katarzyna Gołębiewska, Michał Michalak, JANUSZ K. RYBAKOWSKI · 2018 · Psychiatria Polska
23. Remembering the past to live better in the future: A feasibility randomised controlled trial of memory specificity training for motivation in psychosis
    Clementine Edwards, Philippa Anne Garety, Amy Hardy · 2020 · Journal of Behavior Therapy and Experimental Psychiatry
24. Examining Potential Barriers to mHealth Implementation and Engagement in Schizophrenia: Phone Ownership and Symptom Severity
    Lauren Luther, Benjamin Buck, Melanie W. Fischer, Annalee V. Johnson-Kwochka, George Coffin, Michelle P. Salyers · 2020 · Journal of Technology in Behavioral Science
25. Effectiveness of one-to-one volunteer support for patients with psychosis: protocol of a randomised controlled trial
    Stefan Priebe, Hana Pavlickova, Sandra M Eldridge, Eoin Golden, Paul McCrone, Nick Ockenden, Nancy Pistrang, Michael King · 2016 · BMJ Open
26. Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial
    Samantha V. Abram, Lize De Coster, Brian J. Roach, Bryon A. Mueller, Theo G.M. van Erp, Vince D. Calhoun, Adrian Preda, Kelvin O. Lim, Jessica A. Turner, Judith M. Ford et al. · 2019 · Schizophrenia Bulletin
27. Correspondence between negative symptoms and potential sources of secondary negative symptoms over time
    Aida Farreny, Mark Savill, Stefan Priebe · 2017 · European Archives of Psychiatry and Clinical Neuroscience
28. A Transdiagnostic Network Analysis of Childhood Trauma and Psychopathology
    Yi‐hang Huang, Chao Liu, Jianbiao Zhang, Shuai‐biao Li, Lingling Wang, Hui‐xin Hu, Yuan Cai, Zhenhua Zhu, Min‐yi Chu, Yi Wang et al. · 2024 · Schizophrenia Bulletin
29. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
    Albert Martínez-Pinteño, Gisela Mezquida, Miquel Bioque, Jose M. López-Ilundain, Álvaro Andreu-Bernabeu, Eric P. Zorrilla, Anna Mané, Roberto Rodríguez–Jiménez, Iluminada Corripio, Salvador Sarró et al. · 2022 · European Neuropsychopharmacology
30. Scalability of the Positive and Negative Syndrome Scale in first‐episode schizophrenia assessed by Rasch models
    Lone Baandrup, Peter Allerup, Mette Ødegaard Nielsen, Signe Wegmann Düring, Kirsten Borup Bojesen, Stefan Leucht, Silvana Galderisi, Armida Mucci, Paola Bucci, Celso Arango et al. · 2022 · Acta Psychiatrica Scandinavica
31. Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review
    Claudio Brasso, Gianluca Colli, Rodolfo Sgro, Silvio Bellino, Paola Bozzatello, Cristiana Montemagni, Vincenzo Villari, Paola Rocca · 2023 · Biomedicines
32. Immediate affective motivation is not impaired in schizophrenia
    Fabien Trémeau, Daniel Antonius, Karen A. Nolan, Pamela D. Butler, Daniel C. Javitt · 2014 · Schizophrenia Research
33. The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data
    Mark Savill, Stavros Orfanos, Richard P. Bentall, Ulrich Reininghaus, Til Wykes, Stefan Priebe · 2016 · Psychiatry Research
34. Aberrant parasympathetic reactivity to acute psychosocial stress in male patients with schizophrenia spectrum disorders
    Elizabeth Andersen, Gregory F. Lewis, Ayşenil Belger · 2018 · Psychiatry Research
35. Ethical Reflections on Offering Patients Accelerated Resolution Therapy (ART).
    Evgenia Ivanova, Anzalee Khan, Lora Liharska, Alexander M. Reznik, Sergey Kuzmin, Olga Kushnir, А. П. Агарков, Nikolay A. Bokhan, Tatiana Pogorelova, Olga Khomenko et al. · 2018 · Europe PMC (PubMed Central)
36. Expressive deficits and amotivation as mediators of the associations between cognitive problems and functional outcomes: Results from two independent cohorts
    Edith Jantine Liemburg, Stefanie Enriquez‐Geppert, Klaas J. Wardenaar, Richard Bruggeman, André Aleman, Stynke Castelein, Henderikus Knegtering, Wim Veling, Behrooz Z. Alizadeh, Thérèse van Amelsvoort et al. · 2020 · Schizophrenia Research
37. How do social factors relate to blunted facial affect in schizophrenia? A digital phenotyping study using ambulatory video recordings
    Tovah Cowan, Gregory P. Strauss, Ian Matthew Raugh, Thanh P. Le, Alex S. Cohen · 2022 · Journal of Psychiatric Research
38. Symptômes négatifs de la schizophrénie : une revue des instruments d’évaluation
    Cyril Mach, Sonia Dollfus · 2016 · L Encéphale
39. Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis
    Matthew E. Hudgens‐Haney, Brett A. Clementz, Elena I Ivleva, Matcheri S. Keshavan, Godfrey D. Pearlson, Elliot S. Gershon, Sarah Keedy, John A. Sweeney, Florence Gaudoux, Pierre Bunouf et al. · 2020 · Schizophrenia Bulletin
40. Social motivation and behavior in first-episode psychosis: Unique contributions to social quality of life and social functioning
    Moe, Aubrey M., Weiss, David M., Pine, Jacob G., Wastler, Heather M., Breitborde, Nicholas J.K. · 2021 · Journal of Psychiatric Research
41. The Negative Symptom Inventory-Psychosis Risk (NSI-PR): Psychometric Validation of the Final 11-Item Version
    Gregory P. Strauss, Elaine F. Walker, Nathan T. Carter, Lauren Luther, Vijay Anand Mittal · 2024 · Schizophrenia Bulletin
42. Correlates of real-world goal-directed behavior in schizophrenia
    Jaisal T. Merchant, Erin K. Moran, Michael J. Strube, Deanna M. Barch · 2021 · Psychological Medicine
43. Negative and depressive symptoms differentially relate to real-world anticipatory and consummatory pleasure in schizophrenia
    Jaisal T. Merchant, Erin K. Moran, Deanna M. Barch · 2022 · Schizophrenia Research
44. Giving Back to Families: Evidence and Predictors of Persons with Serious Mental Illness Contributing Help and Support to Families
    Morgan Haselden, Lisa B. Dixon, Ashley M. Overley, Amy N. Cohen, Shirley M. Glynn, Amy L. Drapalski, Sarah Piscitelli, Helle Thorning · 2017 · Community Mental Health Journal
45. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore
    Gurpreet Rekhi, Mei San Ang, Caryn Kai Yan Yuen, Wai Yee Ng, Jimmy Lee · 2018 · Schizophrenia Research
46. Apolipoprotein E-ε4 allele predicts escalation of psychotic symptoms in late adulthood
    Katherine Grace Jonas, Sean Clouston, Kaiqiao Li, Laura J. Fochtmann, Todd Lencz, Anil K. Malhotra, David Colin Cicero, Greg Perlman, Evelyn J. Bromet, Roman Kotov · 2018 · Schizophrenia Research
47. Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders
    Manuel Jesús Cuesta, Ana Maria Sánchez-Torres, Ruth Lorente-Omeñaca, Lucía Moreno-Izco, Víctor Peralta, SegPEPs Group, Alejandro Ballesteros, Elena García de Jalón, Gustavo J. Gil‐Berrozpe, Rebeca Hernández-Antón et al. · 2020 · European Archives of Psychiatry and Clinical Neuroscience
48. Oxytocin and Schizophrenia Spectrum Disorders
    Ulrich Ettinger, René Hurlemann, Raymond C. K. Chan · 2017 · Current topics in behavioral neurosciences
49. Different aspects of emotional processes in apathy: Application of the French translated dimensional apathy scale
    Lise M’Barek, Ratko Radaković, Malika Noquet, Alexandre Laurent, Philippe Allain · 2018 · Current Psychology
50. Clinical and cognitive correlates of unsheltered status in homeless persons with psychotic disorders
    Katiah Llerena, Sonya E. Gabrielian, Michael Foster Green · 2018 · Schizophrenia Research
51. Treatment Outcomes of a Multi-Component Mobile Health Smoking Cessation Pilot Intervention for People with Schizophrenia
    Alyssa M. Medenblik, Adam J. Mann, Tiffany A. Beaver, Eric A. Dedert, Sarah M. Wilson, Patrick S. Calhoun, Jean C. Beckham · 2020 · Journal of Dual Diagnosis
52. Reducing negative symptoms in schizophrenia: Feasibility and acceptability of a combined cognitive-behavioral social skills training and compensatory cognitive training intervention
    Zanjbeel Mahmood, Ryan Van Patten, Amber V. Keller, Hannah C. Lykins, Dimitri Perivoliotis, Eric L. Granholm, Elizabeth W. Twamley · 2020 · Psychiatry Research
53. Antipsychotic dopamine D2 affinity and negative symptoms in remitted first episode psychosis patients
    Franciska de Beer, Ben F. M. Wijnen, Lotte Wouda, Sanne Koops, Shiral S. Gangadin, Wim Veling, Nico J.M. van Beveren, Lieuwe de Haan, Marieke Begemann, Iris E. Sommer · 2024 · Schizophrenia Research
54. Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning
    Nina B. Paul, Gregory P. Strauss, Jessica J. Gates-Woodyatt, Kimberly A. Barchard, Daniel N. Allen · 2023 · European Archives of Psychiatry and Clinical Neuroscience
55. A transdiagnostic network analysis of motivation and pleasure, expressivity and social functioning
    Hui‐xin Hu, Chao Liu, Jianbiao Zhang, Lingling Wang, Min‐yi Chu, Shuai‐biao Li, Qinyu Lv, Simon S. Y. Lui, Li Hui, Zhenghui Yi et al. · 2023 · Nature Mental Health
56. The new challenge in identifying the negative syndrome of schizophrenia
    María Paz García‐Portilla, Julio Bobes · 2013 · Revista de Psiquiatría y Salud Mental (English Edition)
57. Differential blood-based biomarkers of psychopathological dimensions of schizophrenia
    Leticia García-Álvarez, María Paz García‐Portilla, Leticia González-Blanco, Pilar Alejandra Saiz Martinez, Lorena de la Fuente-Tomás, Isabel Menéndez-Miranda, Celso Iglesias García, Julio Bobes · 2016 · Revista de Psiquiatría y Salud Mental (English Edition)
58. Negative symptoms, anxiety, and depression as mechanisms of change of a 12-month trial of assertive community treatment as part of integrated care in patients with first- and multi-episode schizophrenia spectrum disorders (ACCESS I trial)
    Stefanie J. Schmidt, Matthias Lange, Daniel Schöttle, Anne Karow, BENNO GRAF SCHIMMELMANN, Martin Lambert · 2017 · European Archives of Psychiatry and Clinical Neuroscience
59. Compensatory Cognitive Training for psychosis: Effects on negative symptom subdomains
    Zanjbeel Mahmood, Jillian M.R. Clark, Elizabeth W. Twamley · 2018 · Schizophrenia Research
60. Validation of the traditional script Chinese version of the brief negative symptom scale
    Jessica D. Sun, Edgar Wing-ka Ching, Gregory P. Strauss, Anthony O. Ahmed, William W. H. Chui, Joyce Suet Yan Chow · 2020 · Asian Journal of Psychiatry
61. Attention and memory bias to facial emotions underlying negative symptoms of schizophrenia
    Seon-Kyeong Jang, Seon‐Cheol Park, Seung‐Hwan Lee, Yang Seok Cho, Kee‐Hong Choi · 2016 · Cognitive Neuropsychiatry
62. Effects of reward on spatial working memory in schizophrenia.
    Youngsun Cho, Norman H. Lam, Martina Starc, Nicole P. Santamauro, Aleksandar Savić, Caroline Diehl, Charles H. Schleifer, Flora Moujaes, Vinod H. Srihari, Grega Repovš et al. · 2018 · Journal of Abnormal Psychology
63. The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of Psychosis
    Mariola Molina-García, David Fraguas, A. Rey, Gisela Mezquida, Ana Maria Sánchez-Torres, Sílvia Amoretti, António Lobo, Ana María González-Pinto, Álvaro Andreu-Bernabeu, Iluminada Corripio et al. · 2021 · Journal of Clinical Medicine
64. Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping
    Armida Mucci, Stefan Leucht, Giulia Maria Giordano, Luigi Giuliani, Sophia Wehr, Lucia Weigel, Silvana Galderisi · 2025 · Brain Sciences
65. Ecological Momentary Assessment of Social Approach and Avoidance Motivations in Serious Mental Illness: Connections to Suicidal Ideation and Symptoms
    Emma M. Parrish, Samantha A. Chalker, Mayra Cano, Philip D. Harvey, Charles T. Taylor, Amy Elizabeth Pinkham, Raeanne C. Moore, Robert A. Ackerman, Colin A. Depp · 2022 · Archives of Suicide Research
66. Effects of right prefrontal theta-burst transcranial magnetic stimulation or transcranial direct current stimulation on apathy in patients with schizophrenia: A multicenter RCT
    Claire Kos, Leonie Bais, Nicky G. Klaasen, Esther Marije Opmeer, Edith Jantine Liemburg, Klaas J. Wardenaar, Marie‐José van Tol, Henderikus Knegtering, André Aleman · 2024 · Psychiatry Research
67. Study protocol: a randomised controlled trial of cognitive remediation for a national cohort of forensic mental health patients with schizophrenia or schizoaffective disorder
    Ken O’Reilly, Gary J Donohoe, Danny O’Sullivan, Ciarán Coyle, Ronan Mullaney, Paul O’Connell, Catherine Maddock, Andrea Nulty, Padraic O’Flynn, Carina O’Connell et al. · 2016 · BMC Psychiatry
68. Reliability and validity of the self-report version of the apathy evaluation scale in first-episode Psychosis: Concordance with the clinical version at baseline and 12 months follow-up
    Ann Færden, Siv Hege Lyngstad, Carmen Simonsen, Petter Andreas Ringen, Oleg O. Papsuev, Ingrid Dieset, Ole A. Andreassen, Ingrid Agartz, Stephen R. Marder, Ingrid S. Melle · 2018 · Psychiatry Research
69. Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia
    Gurpreet Rekhi, Larry D Alphs, Mei San Ang, Jimmy Lee · 2019 · European Neuropsychopharmacology
70. Motivational and cognitive factors linked to community integration in homeless veterans: study 1 – individuals with psychotic disorders
    Michael Foster Green, Jonathan K. Wynn, Sonya E. Gabrielian, Gerhard Hellemann, William P. Horan, Robert S Kern, Junghee Lee, Stephen R. Marder, Catherine A. Sugar · 2020 · Psychological Medicine
71. Latent structure of self-report negative symptoms in patients with schizophrenia: A preliminary study
    M. Tam, Wang Ling-Ling, Koi‐Man Cheng, Jessica O. Y. Wong, Eric F.C. Cheung, Simon S. Y. Lui, Raymond C. K. Chan · 2021 · Asian Journal of Psychiatry
72. Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)
    Naoki Hashimoto, Atsuhito Toyomaki, Matsuhiko Oka, Keisuke Takanobu, Ryo Okubo, Hisashi Narita, Kan Kitagawa, Niki Udo, Tamaki Maeda, Shinya Watanabe et al. · 2019 · Neuropsychiatric Disease and Treatment
73. Measuring Anhedonia in Schizophrenia-Spectrum Disorders: A Selective Update
    Eduardo Fonseca‐Pedrero, Diane Carol Gooding, Mercedes Paíno, Serafín Lemos Giráldez, José Muñiz · 2014 · Springer eBooks
74. People with schizophrenia do not show the normal benefits of social versus nonsocial attentional cues.
    Lauren T. Catalano, Michael Foster Green, Jonathan K. Wynn, Junghee Lee · 2020 · Neuropsychology
75. The centrality of motivation in psychosocial functioning: Network and bifactor analysis of the Quality of Life Scale in first-episode psychosis.
    Samuel J. Abplanalp, Kim T. Mueser, Daniel Fulford · 2021 · Psychological Assessment
76. The role of defeatist performance beliefs on cognitive effort-cost decision-making in schizophrenia
    Lauren Luther, Andrew Westbrook, Gifty Ayawvi, Iván Ruiz, Ian Matthew Raugh, Angel On Ki Chu, Wing Chung Chang, Gregory P. Strauss · 2023 · Schizophrenia Research
77. Social anhedonia in the daily lives of people with schizophrenia: Examination of anticipated and consummatory pleasure
    Danielle B. Abel, Jenifer L. Vohs, Michelle P. Salyers, Wei Wu, Kyle S. Minor · 2024 · Schizophrenia Research
78. Increased Sensitivity to Effort and Perception of Effort in People with Schizophrenia
    Adam J. Culbreth, Vikram S. Chib, Safa S Riaz, Sanjay Manohar, Masud Husain, James A. Waltz, James M. Gold · 2024 · Schizophrenia Bulletin
79. Self-assessment of negative symptoms – Critical appraisal of the motivation and pleasure – Self-report's (MAP-SR) validity and reliability
    Janina Richter, Klaus Hesse, Mark-Christian Eberle, Kathrin N. Eckstein, Lina Zimmermann, Lisa Schreiber, Carolin P. Burmeister, Dirk Wildgruber, Stefan Klingberg · 2018 · Comprehensive Psychiatry
80. The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness
    Teresa Vargas, Anthony O. Ahmed, Gregory P. Strauss, Cassandra M Brandes, Elaine F. Walker, Robert W. Buchanan, James M. Gold, Vijay Anand Mittal · 2019 · Translational Psychiatry
81. Negative Symptom Domains Are Associated With Verbal Learning in Adolescents With Early Onset Psychosis
    Lynn Egeland Mørch-Johnsen, Runar Elle Smelror, Dimitrios Andreou, Cláudia Barth, Cecilie Haggag Johannessen, Kirsten Wedervang‐Resell, Laura Anne Wortinger, Ricardo Díaz Sánchez, Gamaliel Victoria, Torill Ueland et al. · 2022 · Frontiers in Psychiatry
82. Cluster analysis of negative symptoms identifies distinct negative symptom subgroups
    Nina B. Paul, Gregory P. Strauss, Jessica J. Gates-Woodyatt, Michelle G. Paul, Jennifer Reid Keene, Daniel N. Allen · 2022 · Schizophrenia Research
83. Bridge centrality network structure of negative symptoms in people with schizophrenia
    Lingling Wang, M. Tam, Karen K. Y. Ho, Karen S. Y. Hung, Jessica O. Y. Wong, Simon S. Y. Lui, Raymond C. K. Chan · 2022 · European Archives of Psychiatry and Clinical Neuroscience
84. Decision value signals in the ventromedial prefrontal cortex and motivational and hedonic symptoms across mood and psychotic disorders
    Min Kang Souther, Daniel H. Wolf, Rebecca Kazinka, Sangil Lee, Kosha Ruparel, Mark A. Elliott, Anna Xu, Matthew Cieslak, Greer E. Prettyman, Theodore Daniel Satterthwaite et al. · 2022 · NeuroImage Clinical
85. Metacognition moderates the relationship between self-reported and clinician-rated motivation in schizophrenia
    Lauren Luther, Kelsey A. Bonfils, Melanie W. Fischer, Annalee V. Johnson-Kwochka, Michelle P. Salyers · 2019 · Schizophrenia Research Cognition
86. Motivational and cognitive correlates of community integration in homeless veterans entering a permanent supported housing program.
    William P. Horan, Jonathan K. Wynn, Sonya E. Gabrielian, Shirley M. Glynn, Gerhard Hellemann, Robert S Kern, Junghee Lee, Stephen R. Marder, Catherine A. Sugar, Michael Foster Green · 2019 · American Journal of Orthopsychiatry
87. Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project
    Benedicto Crespo‐Facorro, Miquel Bernardo, Josep M. Argimón, Manuel Arrojo, María Fe Bravo‐Ortiz, Ana Cabrera-Cifuentes, Julián Carretero Román, Manuel Franco, María Paz García‐Portilla, Josep Maria Haro et al. · 2017 · Revista de Psiquiatría y Salud Mental (English Edition)
88. The remediation effects of working memory training in schizophrenia patients with prominent negative symptoms
    Li, Xu, Chu, Min-yi, Lv, Qin-yu, Hu, Hui-xin, Li, Zhi, Yi, Zheng-hui, Wang, Jin-hong, Zhang, Jian-ye, Lui, Simon S. Y., Cheung, Eric F. C. et al. · 2019 · Cognitive Neuropsychiatry
89. The Effects of Cognitive Remediation on Negative Symptoms in Schizophrenia-Spectrum Illness: A Meta-analytic Investigation of Efficacy
    Grace Melville, Clara Curi Preisig, Michael Zheng, Matthew M. Kurtz · 2024 · Schizophrenia Bulletin
90. Preliminary evidence that fatigue contributes to anhedonia in stable individuals diagnosed with schizophrenia
    Yasmine Laraki, Sophie Bayard, Amandine Décombe, Delphine Capdevielle, Stéphane Raffard · 2023 · Frontiers in Psychiatry
91. Peak Alpha Frequency in Schizophrenia, Bipolar Disorder, and Healthy Volunteers: Associations With Visual Information Processing and Cognition
    Lauren T. Catalano, Eric A. Reavis, Jonathan K. Wynn, Michael Foster Green · 2024 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
92. Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder
    Sílvia Corbera, Bruce E. Wexler, Morris David Bell, Brian P. Pittman, Kevin Archer Pelphrey, Godfrey D. Pearlson, Michal Assaf · 2024 · Schizophrenia Research
93. [The clinic of apathy in schizophrenia: a critical review of the issue].
    H. Yazbek, S. Raffard, Jonathan Del-Monte, F. Pupier, A. Larue, J. Boulenger, M. Gély-Nargeot, D. Capdevielle · 2014 · L'Encephale
94. Assessment of the efficacy of a fatigue management therapy in schizophrenia: study protocol for a randomized, controlled multi-centered study (ENERGY)
    Stéphane Raffard, Nicolas Rainteau, Sophie Bayard, Yasmine Laraki, Joanna L. Norton, Delphine Capdevielle · 2020 · Trials
95. Associations Between Cognitive and Physical Effort–Based Decision Making in People With Schizophrenia and Healthy Control Subjects
    Adam J. Culbreth, Sally D. Dershwitz, Deanna M. Barch, Erin K. Moran · 2023 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
96. Social pleasure in daily life: A meta-analysis of experience sampling studies in schizophrenia
    Danielle B. Abel, Kyle S. Minor · 2023 · Schizophrenia Research
97. Impact of Reward and Loss Anticipation on Cognitive Control: An Event-Related Potential Study in Subjects With Schizophrenia and Healthy Controls
    Annarita Vignapiano, Armida Mucci, Eleonora Merlotti, Giulia Maria Giordano, Antonella Amodio, Davide Palumbo, Silvana Galderisi · 2017 · Clinical EEG and Neuroscience
98. Disrupted salience processing involved in motivational deficits for real-life activities in patients with schizophrenia
    Byung-Hoon Kim, Yu‐Bin Shin, S.-H. Kyeong, Seon-Koo Lee, Jae‐Jin Kim · 2018 · Schizophrenia Research
99. Fronto-limbic white matter fractional anisotropy and body mass index in first-episode schizophrenia spectrum disorder patients compared to healthy controls
    Hilmar Klaus Luckhoff, Stefan S. du Plessis, Freda Scheffler, Lebogang Phahladira, Sanja Kilian, Chanellé Buckle, Retha Smit, Bonginkosi Chiliza, Laila Asmal, Robin Alexander Emsley · 2020 · Psychiatry Research Neuroimaging
100. Negative symptoms in psychosis: A scoping review of qualitative studies
     John Lyne, Francesco Piacenza, Paul M. Crowley, Justin Smyth, Brian N. O'Donoghue, Keith Gaynor, Mary Clarke · 2025 · Schizophrenia Research